| Phase 2 Etirinotecan Pegol in Refractory Brain Metastases & Advanced Lung Cancer / Metastatic Breast Cancer (NCT02312622) | Joel Neal | 2015-08-01 |
| Quantitative MRI in Assessing Disease in Patients With Brain Tumors (NCT02269111) | Vanderbilt-Ingram Cancer Center | 2015-04-01 |
| Stereotactic Radiation Therapy and Ipilimumab in Treating Patients With Metastatic Melanoma (NCT02107755) | Ohio State University Comprehensive Cancer Center | 2014-09-05 |
| Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study (NCT01891318) | Case Comprehensive Cancer Center | 2013-07-03 |
| Stereotactic Radiosurgery in Treating Patients With Large Brain Metastases (NCT01843413) | Case Comprehensive Cancer Center | 2013-07-02 |
| Voxel Based Diffusion Tensor Imaging in Predicting Response in Patients With Brain Metastases Undergoing Whole Brain Radiation Therapy or Stereotactic Radiosurgery (NCT02277561) | Albert Einstein College of Medicine | 2013-04-01 |
| Phase I Study of Ipilimumab Combined With Whole Brain Radiation Therapy or Radiosurgery for Melanoma (NCT01703507) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2012-11-09 |
| Liposomal Cytarabine and High-Dose Methotrexate in Treating Patients With Central Nervous System Metastases From Breast Cancer (NCT00992602) | University of Washington | 2011-04-01 |
| Sorafenib Tosylate and Stereotactic Radiosurgery in Treating Patients With Brain Metastases (NCT01276210) | Vanderbilt-Ingram Cancer Center | 2011-02-01 |
| Bafetinib in Treating Patients With Recurrent High-Grade Glioma or Brain Metastases (NCT01234740) | City of Hope Medical Center | 2010-12-01 |
| Lapatinib in Treating Brain Metastases in Patients With Stage IV Breast Cancer and Brain Metastases (NCT00098605) | National Cancer Institute (NCI) | 2004-10-01 |
| Temozolomide and Thalidomide in Treating Patients With Brain Metastases Secondary to Melanoma (NCT00072163) | National Cancer Institute (NCI) | 2003-10-01 |
| Radiation Therapy With or Without Thalidomide in Treating Patients With Brain Metastases (NCT00033254) | National Cancer Institute (NCI) | 2002-03-01 |
| Vemurafenib Combined With Whole Brain Radiation Therapy or Radiosurgery in Patients With BRAF Mutation-Positive Melanoma and Brain Metastases (NCT02145910) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | |